tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Sykes, 81 are a HOLD (33.47%), 132 are a BUY (54.55%), 29 are a SELL (11.98%).
Analyst Matthew Sykes, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 69.79% that have a potential upside of 22.06% achieved within 194 days.
Matthew Sykes’s has documented 462 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.
Most recent stock forecast was given on SHC, Sotera Health Co at 05-Jun-2026.
Analyst best performing recommendations are on ZY (ZYMERGEN).
The best stock recommendation documented was for ZY (ZYMERGEN) at 8/4/2021. The price target of $12 was fulfilled within 1 day with a profit of $3.75 (45.45%) receiving and performance score of 454.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Apr-2025
$200
$-7.66 (-3.69%)
$235
1 months 19 days ago
(22-Jul-2026)
1/5 (20%)
$20.86 (11.64%)
16
Buy Since 23-Apr-2025
$220
$12.34 (5.94%)
$260
1 months 19 days ago
(22-Jul-2026)
9/15 (60%)
$40.86 (22.81%)
154
Hold Since 15-Dec-2025
$195
$-12.66 (-6.10%)
$212
1 months 19 days ago
(22-Jul-2026)
9/14 (64.29%)
$15.86 (8.85%)
416
Buy Since 27-Jul-2020
$236
$28.34 (13.65%)
$270
1 months 19 days ago
(22-Jul-2026)
7/21 (33.33%)
$56.86 (31.74%)
248
Buy Since 04-Jan-2021
$230
$22.34 (10.76%)
$225
2 months 4 days ago
(06-Jul-2026)
6/10 (60%)
$36.38 (18.79%)
78
Which stock is Matthew Sykes most bullish on?
What Year was the first public recommendation made by Matthew Sykes?
